Suppr超能文献

一种用于分离和测定苯磺酸氨氯地平、缬沙坦和氢氯噻嗪复方片剂剂型中杂质的新型快速稳定性指示超高效液相色谱法。

A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form.

作者信息

Vojta Jiří, Jedlička Aleš, Coufal Pavel, Janečková Lucie

机构信息

Zentiva, k.s., Praha, U Kabelovny 130, 102 37 Praha 10, Czech Republic; Department of Analytical Chemistry, Charles University in Prague, Faculty of Science, Hlavova 8, 128 43 Praha 2, Czech Republic.

Zentiva, k.s., Praha, U Kabelovny 130, 102 37 Praha 10, Czech Republic.

出版信息

J Pharm Biomed Anal. 2015 May 10;109:36-44. doi: 10.1016/j.jpba.2015.01.059. Epub 2015 Feb 18.

Abstract

A new rapid stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form was developed. The separation of Ph. Eur. related substances of amlodipine besylate (A, B, D, E, F, G), hydrochlorothiazide (A, B, C), valsartan (B, C), two other valsartan impurities (S)-2-(N-{[2'-cyanobiphenyl-4-yl]methyl}pentanamido)-3-methylbutanoic acid and (S)-3-methyl-2-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methylamino}butanoic acid and several unknown impurities was achieved by reversed phase liquid chromatography with UV detection. The detection wavelengths were set as follows: 225nm for valsartan, its impurities and for the impurity D of amlodipine, 271nm for hydrochlorothiazide and its impurities and 360nm for amlodipine and its impurities except for impurity D. Zorbax Eclipse C8 RRHD (100mm×3.0mm, 1.8μm) was used as a separation column and the analytes were eluted within 11min by a programmed gradient mixture of 0.01M phosphate buffer pH 2.5 and acetonitrile. The method was successfully validated in accordance to the International Conference of Harmonization (ICH) guidelines for amlodipine besylate and its impurity D, valsartan and its impurity C and hydrochlorothiazide and its impurities A, B and C. The triple-combined tablets were exposed to thermal, higher humidity, acid, alkaline, oxidative and photolytic stress conditions. Stressed samples were analyzed by the proposed method. All the significant degradation products and impurities were satisfactory separated from each other and from the principal peaks of drug substances. The peak purity test complied for peaks of amlodipine, valsartan and hydrochlorothiazide in all the stressed samples and indicated no co-elution of degradation products. The method was found to be precise, linear, accurate, sensitive, specific, robust and stability-indicating and could be used as a routine purity test method for amlodipine besylate, valsartan, hydrochlorothiazide and their pharmaceutical combinations.

摘要

开发了一种新的快速稳定性指示超高效液相色谱法,用于分离和测定苯磺酸氨氯地平、缬沙坦和氢氯噻嗪复方片剂剂型中的杂质。采用反相液相色谱-紫外检测法实现了苯磺酸氨氯地平(A、B、D、E、F、G)、氢氯噻嗪(A、B、C)、缬沙坦(B、C)、另外两种缬沙坦杂质(S)-2-(N-{[2'-氰基联苯-4-基]甲基}戊酰胺基)-3-甲基丁酸和(S)-3-甲基-2-{[2'-(1H-四氮唑-5-基)联苯-4-基]甲基氨基}丁酸以及几种未知杂质的分离。检测波长设置如下:缬沙坦及其杂质以及氨氯地平杂质D为225nm,氢氯噻嗪及其杂质为271nm,氨氯地平及其除杂质D外的杂质为360nm。使用Zorbax Eclipse C8 RRHD(100mm×3.0mm,1.8μm)作为分离柱,通过0.01M pH 2.5的磷酸盐缓冲液和乙腈的程序梯度混合物在11分钟内洗脱分析物。该方法按照国际协调会议(ICH)指南对苯磺酸氨氯地平及其杂质D、缬沙坦及其杂质C以及氢氯噻嗪及其杂质A、B和C成功进行了验证。将三联复方片剂置于热、高湿度、酸、碱、氧化和光解应激条件下。用所提出的方法对应激样品进行分析。所有显著的降解产物和杂质彼此之间以及与原料药主峰均得到了满意的分离。峰纯度测试适用于所有应激样品中氨氯地平、缬沙坦和氢氯噻嗪的峰,表明没有降解产物共洗脱。该方法被发现具有精密度、线性、准确性、灵敏性、特异性、稳健性和稳定性指示性,可作为苯磺酸氨氯地平、缬沙坦、氢氯噻嗪及其药物组合物的常规纯度测试方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验